Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
National Beverage
FIZZ
$2.96B
| $11.6M | ﹤0.01% |
271,658
+7,075
| +3% | +$331K |
|
1952
Travere Therapeutics
TVTX
$5.12B
| $11.5M | ﹤0.01% |
661,603
+94,194
| +17% | +$1.67M |
|
1953
Appian
APPN
$2.04B
| $11.5M | ﹤0.01% |
348,932
+14,085
| +4% | +$503K |
|
1954
Fortrea Holdings
FTRE
$1.73B
| $11.4M | ﹤0.01% |
612,897
+22,469
| +4% | +$438K |
|
1955
Wave Life Sciences
WVE
$1.17B
| $11.3M | ﹤0.01% |
914,469
+69,852
| +8% | +$932K |
|
1956
Protolabs
PRLB
$2.08B
| $11.3M | ﹤0.01% |
289,345
-41,453
| -13% | -$1.49M |
|
1957
Sable Offshore Corp
SOC
$865M
| $11.3M | ﹤0.01% |
493,042
+107,475
| +28% | +$2.35M |
|
1958
GlobalFoundries
GFS
$28.8B
| $11.3M | ﹤0.01% |
262,872
+48,380
| +23% | +$2.03M |
|
1959
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.6B
| $11.3M | ﹤0.01% |
377,363
-16,081
| -4% | -$482K |
|
|
INFN
1960
DELISTED
Infinera Corporation Common Stock
INFN
| $11.3M | ﹤0.01% |
1,713,396
+14,588
| +0.9% | +$97.2K |
|
1961
Grid Dynamics Holdings
GDYN
$562M
| $11.2M | ﹤0.01% |
505,596
+41,390
| +9% | +$723K |
|
1962
Live Oak Bancshares
LOB
$2.05B
| $11.2M | ﹤0.01% |
284,002
+5,181
| +2% | +$233K |
|
|
ODP
1963
DELISTED
ODP
ODP
| $11.2M | ﹤0.01% |
491,587
+10,137
| +2% | +$282K |
|
1964
Vital Farms
VITL
$521M
| $11.2M | ﹤0.01% |
296,416
+42,982
| +17% | +$1.53M |
|
|
MTTR
1965
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $11.1M | ﹤0.01% |
2,350,514
+37,569
| +2% | +$178K |
|
1966
SunCoke Energy
SXC
$749M
| $11.1M | ﹤0.01% |
1,040,090
-164,690
| -14% | -$1.76M |
|
|
BRKL
1967
DELISTED
Brookline Bancorp
BRKL
| $11.1M | ﹤0.01% |
939,755
-76,648
| -8% | -$889K |
|
1968
Viridian Therapeutics
VRDN
$2.22B
| $11M | ﹤0.01% |
575,070
+58,857
| +11% | +$1.28M |
|
1969
Progyny
PGNY
$2.46B
| $11M | ﹤0.01% |
637,633
-35,813
| -5% | -$556K |
|
1970
Praxis Precision Medicines
PRAX
$8.61B
| $11M | ﹤0.01% |
142,892
+5,840
| +4% | +$423K |
|
1971
Novavax
NVAX
$1.25B
| $11M | ﹤0.01% |
1,365,414
+39,906
| +3% | +$385K |
|
1972
iShares Core S&P US Value ETF
IUSV
$27.5B
| $11M | ﹤0.01% |
118,482
-14,277
| -11% | -$1.37M |
|
1973
CareDx
CDNA
$2.43B
| $11M | ﹤0.01% |
511,922
+12,442
| +2% | +$303K |
|
1974
Ubiquiti
UI
$34.1B
| $10.9M | ﹤0.01% |
32,977
-41
| -0.1% | -$12.3K |
|
1975
Perella Weinberg Partners
PWP
$1.26B
| $10.9M | ﹤0.01% |
457,759
+23,754
| +5% | +$551K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.